Related Experiment Video
Updated: Jun 17, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
ATM- and ATR-mediated response to DNA damage induced by a novel camptothecin, ST1968
Valentina Zuco1, Valentina Benedetti, Franco Zunino
1Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy.
Abstract:
DNA damage response and checkpoint activation are expected to influence the sensitivity to DNA-damaging agents. This study was designed to investigate the DNA damage response to the novel camptothecin, ST1968, in two tumor cell lines with a different biological background (A2780 and KB), which underwent distinct cell cycle perturbations and cell death modalities. Following treatment with the camptothecin or ionizing radiation, both inducing double-strand DNA breaks, the ovarian carcinoma A2780 cells exhibited activation of the ATM-Chk2 pathway and early induction of apoptosis. In contrast, the squamous carcinoma KB cells exhibited activation of ATR-Chk1 pathway, a persistent G(2)/M-phase arrest, cellular senescence, mitotic catastrophe and delayed apoptosis, suggesting a defective ATM pathway. The cellular response to UV-induced DNA damage, which activates ATR-Chk1 pathway, was similar in the two cell lines exhibiting early apoptosis induction. Inhibition of ATM in A2780 cells, resulting in reduced phosphorylation of Chk2, enhanced ST1968-induced apoptosis, but had no effect in KB cells. The susceptibility to camptothecin-induced apoptosis of A2780 cells was likely p53-dependent but not related to the activation of the ATM pathway. In contrast, the inhibition of Chk1 enhanced apoptosis response in KB cell but not in A2780. Thus, depending on the biological context, the camptothecin activated ATM-Chk2 or ATR-Chk1 pathways, both having a protective role. In conclusion, our results are consistent with the interpretation that the modality of cell death response is not the critical determinant of sensitivity to camptothecins, and support the interest of inhibition of checkpoint kinases to improve the efficacy of camptothecins.
Insights
This study reveals that DNA damage response pathways, ATM-Chk2 and ATR-Chk1, play protective roles against camptothecin ST1968. Inhibiting checkpoint kinases like ATM or Chk1 can enhance cancer cell death, improving drug efficacy.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- DNA damage response (DDR) and checkpoint activation influence sensitivity to DNA-damaging agents.
- Camptothecins are a class of anticancer drugs that induce DNA damage.
- Understanding differential cellular responses to DDR is crucial for optimizing cancer therapy.
Purpose of the Study:
- To investigate the DNA damage response to the novel camptothecin ST1968 in two distinct tumor cell lines (A2780 and KB).
- To elucidate the roles of ATM-Chk2 and ATR-Chk1 pathways in mediating cellular responses and sensitivity to ST1968.
- To explore the potential of inhibiting checkpoint kinases to enhance camptothecin efficacy.
Main Methods:
- Treatment of A2780 (ovarian carcinoma) and KB (squamous carcinoma) cells with camptothecin ST1968 or ionizing radiation.
- Analysis of DNA damage response pathways, including ATM-Chk2 and ATR-Chk1 activation.
- Assessment of cell cycle perturbations, cell death modalities (apoptosis, senescence, mitotic catastrophe), and effects of kinase inhibition (ATM, Chk1).
Main Results:
- A2780 cells showed ATM-Chk2 activation and early apoptosis, while KB cells exhibited ATR-Chk1 activation, G(2)/M arrest, senescence, and delayed apoptosis, suggesting a defective ATM pathway in KB cells.
- UV-induced DNA damage activated ATR-Chk1 similarly in both cell lines, leading to early apoptosis.
- Inhibition of ATM enhanced ST1968-induced apoptosis in A2780 cells but not KB cells.
- Inhibition of Chk1 enhanced apoptosis in KB cells but not A2780 cells.
- Camptothecin-induced apoptosis in A2780 cells was p53-dependent but not ATM-related.
Conclusions:
- The camptothecin ST1968 activates either ATM-Chk2 or ATR-Chk1 pathways depending on the cellular context, with both pathways conferring a protective role.
- Cell death modality is not the critical determinant of sensitivity to camptothecins.
- Inhibition of checkpoint kinases (ATM, Chk1) holds promise for improving the efficacy of camptothecins in cancer treatment.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...

